Harvard Bioscience Q4 Adj EPS $0.04 Misses $0.05 Estimate, Sales $28.15M Miss $29.11M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is unchanged from the same period last year. The company reported quarterly sales of $28.15 million which missed the analyst consensus estimate of $29.11 million by 3.29 percent. This is a 0.96 percent decrease over sales of $28.43 million the same period last year.